Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001172661-25-004855·MANGROVE PARTNERS IM, LLC
Schedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share · CUSIP: 589492107
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mangrove Partners IM, LLC
Shares: 38,952,900.00 · Class: 4.9%
- Nathaniel August
Shares: 38,952,900.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-004855
- Form type
- SCHEDULE 13G/A
- Filer
- MANGROVE PARTNERS IM, LLC
- CIK
- CIK 1535392
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership